| EMA number | EMEA/H/C/005381 |
| ATC code | L01EM04 |
| Authorisation | 19 May 2021 |
| Withdrawn | 16 February 2026 |
| Revision | 3 |
Copiktra monotherapy is indicated for the treatment of adult patients with: Relapsed or refractory chronic lymphocytic leukaemia (CLL) after at least two prior therapies. Follicular lymphoma (FL) that is refractory to at least two prior systemic therapies.